Type: Poster
Ali Al-Mousawi, MD1,2,3*, Stine Ulrik Mikkelsen, MD, PhD1,2,3*, Amalie Bach Nielsen, MD2*, Anders Pommer Vallentin, MD1,2*, Astrid Ø. Mortensen1,2*, Zachary Madaj3*, Jakob Jespersen2*, Linn Gillberg, PhD, MSc1,2*, Jakob Werner Hansen, MD, PhD1,2*, Mette Klarskov Andersen, MD, PhD4*, Bo Mortensen, MD1,5*, Marianne Tang Severinsen, MD, PhD6*, Casey O'Connell, MD7*, Jens Lykkesfeldt, Professor PhD, DMSc8*, Peter A. Jones, PhD, DSc3* and Kirsten Gronbaek, MD, PhD, PR1,3,9
1Dept. of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
2Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
3Department of Epigenetics, Van Andel Institute, Grand Rapids, MI
4Department of Clinical Genetics, Centre of Diagnostic Investigations, Copenhagen University Hospital, Copenhagen, Denmark
5Herlev University Hospital, Herlev, Denmark
6Aalborg University Hospital, Aalborg, Denmark
7USC Norris Cancer Center, Los Angeles, CA
8Life Science Faculty, University of Copenhagen, Copenhagen, Denmark
9Rigshospitalet, University of Copenhagen, Copenhagen N, Denmark
Huafeng Wang1*, Xudong Wei, MD, PhD2*, Yang Liang3, Jianyu Weng, MD, PhD4*, Wenjuan He5*, Chunkang Chang, MD, PhD6*, Suning Chen, MD, PhD7*, Hongbing Ma8*, Zi Chen, MD, PhD9*, Lichuang Men, MSc9*, Lihui Liu, MD, PhD9*, Xiaohong Tian, MD9*, Zhang Zhang, MD, PhD10*, Danhua Cong, MS9*, Dajun Yang, MD, PhD10,11*, Yifan Zhai, MD, PhD10,12 and Jie Jin, MD, PhD13*
1The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
2Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
3Sun Yat-sen University Cancer Center, Guangzhou, China
4Guangdong Provincial People's Hospital, Guangdong, China
5Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
6Shanghai Sixth People’s Hospital, Shanghai, China
7The first Affiliated Hospital of Soochow University, Suzhou, China
8West China Hospital, Sichuan University, Chengdu, China
9Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, China
10Ascentage Pharma Group Inc., Rockville, MD
11Department of Experimental Research, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
12State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
13The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
Rurika Okuda, MSc, BS1,2*, Yotaro Ochi, MD, phd1*, Tetsuichi Yoshizato, MD, PhD1, Yasuhito Nannya1*, Yoshiko Atsuta3*, Yuichi Shiraishi4*, Yusuke Shiozawa, MD1,5*, Hiroko Tanaka6*, Makoto Onizuka7, Kenichi Chiba4*, Hidehiro Itonaga, MD, PhD8, Yoshinobu Kanda, MD, PhD9*, Yasushi Miyazaki, MD, PhD8, Keizo Horibe, MD, PhD10*, Satoru Miyano, PhD6*, Hideki Makishima, MD, PhD1 and Seishi Ogawa, MD, PhD2,11
1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
2Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan
3The Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan
4Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
5Department of Pediatrics, The University of Tokyo, Tokyo, Japan
6M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan
7Department of Hematology/Oncology, Tokai University, Isehara, Japan
8Japan Adult Leukemia Study Group, and Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan
9Division of Hematology, Jichi Medical University, Tochigi, Japan
10Clinical Research Center, NHO Nagoya Medical Center, Nagoya, Japan
11Kyoto University, Sakyoku, KYO, Japan
Guillermo Montalban-Bravo, MD1, Kelly S. Chien, MD1, Sanam Loghavi, MD2, Rashmi Kanagal-Shamanna, MD3, Anuya A. Natu, MBBS4*, Mark Gurney, MB, BCh, BAO4*, Alexandre Bazinet, MD5*, Danielle Hammond, MD1, Gautam Borthakur, MD6, Mahesh Swaminathan, MD1*, Courtney D. DiNardo, MD, MSc1, Tapan M. Kadia, MD1, Farhad Ravandi, MBBS7, Naval Daver, MD8, Naveen Pemmaraju, MD9, Ghayas C. Issa, MD1, Terra L. Lasho, PhD10, Christy Finke, BS4*, Aref Al-Kali, MD4, Clifford M. Csizmar, MD, PhD11, Hassan B Alkhateeb, MD4*, Naseema Gangat, MBBS4, Abhishek A. Mangaonkar, MBBS10, Ayalew Tefferi, MD4, Hagop Kantarjian, MD1, Guillermo Garcia-Manero, MD1 and Mrinal M. Patnaik, MD, MBBS10
1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
4Division of Hematology, Mayo Clinic, Rochester, MN
5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
6Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
8MD Anderson Cancer Center, Houston, TX
9Department of Leukemia, The University of Texas MD Anderson Cancer Center, Bellaire, TX
10Mayo Clinic, Rochester, MN
11Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
Laura Palomo, PhD1*, Mireia Morgades2*, Manja Meggendorfer, PhD3, Marina Díaz-Beyá, MD, PhD4*, Helena Pomares5*, Guillermo Ramil López, MD6*, Mariam Ibañez7*, Mar Tormo, MD8, Felix Lopez, MD9*, Alejandro Avendaño Pita10*, Juan Carlos Caballero11*, Jordi Vila Bou12*, Juan Restrepo13*, Veronica Roldan14*, Pilar Galán15*, Estefania Cerezo Velasco, MD16*, Cristina Notario17*, ANA Garcia Feria18*, Torsten Haferlach, MD19, Sandra Castaño-Díez, MD4*, Esther Alonso20*, Marta Pratcorona, MD, PhD6*, Rosa Collado21*, Marisa Calabuig22*, Pamela Acha23*, Gerardo Aguilar-Monserrate11*, Marta Cabezón2*, Neus Ruiz Xiville, PhD2*, Maria Diez-Campelo, MD, PhD24*, Lurdes Zamora, PhD25* and Blanca Xicoy, MD26*
1ICO-Hospital Germans Trias i Pujol, Institut de Recerca contra la Leucèmia Josep Carreras (IJC), Universitat Autònoma de Barcelona, Badalona, ESP
2ICO-Hospital Germans Trias i Pujol, Institut de Recerca contra la Leucèmia Josep Carreras (IJC), Universitat Autònoma de Barcelona, Badalona, Spain
3MLL Munich Leukemia Laboratory, Munich, Bavaria, Germany
4Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain
5Clinical Hematology Department, ICO-Hospitalet, Hospital Durán i Reynals. IDIBELL, Barcelona., Barcelona, Spain
6Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
7Hospital General Universitario de Valencia, Valencia, ESP
8Department of Hematology and Medical Oncology,, Hospital Clínico Universitario de Valencia. INCLIVA Biomedical Research Institute, Valencia, Spain
9Experimental Hematology, Hospital Universitario Vall d’Hebrón, Institut d’Oncologia Vall d’Hebrón (VHIO), Barcelona, ESP
10Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
11Hospital Clínico Universitario de Valladolid, Valladolid, Spain
12Institut Català d’Oncologia - Hospital Universitari de Girona Dr. Josep Trueta, Girona, ESP
13Institut Català d’Oncologia - Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain
14Hospital Universitario Cruces, Bilbao, Spain
15Complejo Asistencial de Segovia, Segovia, ESP
16Hematology Department, Consorcio Sanitario de Terrassa, Terrassa, Spain
17Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain
18Hospital Universitario Doctor Peset, Valencia, Spain
19MLL Munich Leukemia Laboratory, Munich, Germany
20Hospital De Bellvitge, L'Hospitalet De Llobregat, Ba, ESP
21Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia, ESP
22Hospital Clínico Universitario de Valencia, Valencia, Spain
23Experimental Hematology, Hospital Universitario Vall d’Hebrón, Institut d’Oncologia Vall d’Hebrón (VHIO), Barcelona, Spain
24Hospital Clínico Universitario de Salamanca, Salamanca, Spain
25Haematology Department, ICO-Hospital Germans Trias i Pujol, Institut de Recerca contra la Leucèmia Josep Carreras (IJC), Universitat Autònoma de Barcelona, Badalona, Spain
26Hematology Service, ICO-Hospital Germans Trias i Pujol, Institut de Recerca contra la Leucèmia Josep Carreras (IJC), Universitat Autònoma de Barcelona, Badalona, Spain
Guru Subramanian Guru Murthy, MBBS1, Somedeb Ball, MD2, Jonathan Feld, MD3, Ramzi Abboud4, Michael Haddadin, MBBS5, Shyam Ajay Patel, MD, PhD6, Ashwin Kishtagari, MBBS7, Hayley Hawkins8*, Veronica Guerra, MD9*, Emily Dworkin, PharmD10*, Reema K. Tawfiq, MD11, Dominika Dulak, MD12, Amber Feng, MD13*, Christina Cotte14*, Adam Cohen-Nowak15*, Asmita Shukla, MD16, Suresh Kumar Balasubramanian, MD17, Eric S. Winer, MD18, Charles Foucar, MD19, Yasmin Abaza, MD15, Rory M. Shallis, MD20, Chenyu Lin, MD21, Talha Badar, MD22, Anand Ashwin Patel, MD23, Annie Im, MD24, Aniko Szabo, PhD1* and Ehab L. Atallah, MD25
1Medical College of Wisconsin, Milwaukee, WI
2Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Nashville, TN
3Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
4Washington University School of Medicine, Clayton, MO
5Fred & Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, NE
6UMass Chan Medical School, Worcester, MA
7Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Franklin, TN
8Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN
9Washington University St Louis, St Louis
10Department of Pharmacy, University of Chicago, Chicago, IL
11Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
12Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA
13Duke University Hospital, Durham, NC
14Yale University, New Haven, CT
15Northwestern University, Chicago, IL
16Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI
17Department of Oncology, Karmanos Cancer Institute/Wayne State University, Troy, MI
18Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
19University of New Mexico, Ann Arbor, MI
20Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, Killingworth, CT
21Duke University Cancer Institute, Durham, NC
22Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
23Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
24UPMC Hillman Cancer Center, Univ. of Pittsburgh Cancer Institute, Pittsburgh, PA
25Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
Katharina S. S. Götze, MD1,2,3, Anna Hecht, MD4*, Anne Sophie Kubasch, MD5, Maria Diez-Campelo, MD, PhD6*, Georg Stüssi, MD7*, David Valcarcel, MD, PhD8, Patricia Font Lopez, MD9*, Elvira Mora Castera, MD10*, Blanca Xicoy, MD11*, Teresa Bernal Del Castillo, MD, PhD12*, Dominik Wolf, M.D.13*, Nicola Andina, MD, PhD14*, Nicolas Bonadies, MD15, Gregor Stehle, MD16*, Karoline V. Gleixner, MD17*, Klaus H Metzeler, MD5, Arnold Schröder18*, Dorothea Schipp18*, Maria Tormo, MD19*, Ana Alfonso Pierola, MD, PhD20*, Aristoteles Giagounidis, MD21, Martin Puttrich18* and Uwe Platzbecker, MD5
1Department of Medicine III, Hematology and Oncology, Technical University of Munich (TUM) School of Medicine and Health, Munich, Bavaria, Germany
2German Cancer Consortium (DKTK), partner site Munich, Heidelberg, Germany
3Bavarian Center for Cancer Research (BZKF), Munich, Germany
4Department of Medicine III, Hematology and Oncology, Technical University of Munich (TUM) School of Medicine and Health, Munich, Germany
5Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany
6Hospital Clínico Universitario de Salamanca, Salamanca, Spain
7Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale, Bellinzona, Switzerland
8Department of Hematology and Oncology, Hospital Universitario Vall d'Hebron, Barcelona, Spain
9Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
10Department of Hematology, University Hospital La Fe of Valencia, VALENCIA, ESP
11Department of Hematology, University Hospital Català d' Oncologia de Badalona (German University Trias y Pujol), Spain, Badalona, Spain
12Hospital Universitario Central de Asturias, Oviedo, Spain
13University Hospital of Internal Medicine V (Hematology and Oncology), Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria
14Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, Bern, Switzerland
15Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
16University Hospital Basel, Department of Hematology, Basel, Basel Stadt, CHE
17Division of Hematology & Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria
18GWT-TUD GmbH, Dresden, Germany
19Department of Hematology, University Hospital of Valencia, Valencia, Spain
20University Hospital of Navarra, Pamplona, Spain
21Clinic for Hematology, Oncology and Palliative Care Marien Hospital Düsseldorf, Dusseldorf, Germany
Thomas Wiseman1,2,3*, Michaela Spooner, BSc(LabMed)3*, Shreyas Khanna1,2,3*, Kevin Hung, MBBS, FRACP, FRCPA1, Carla Toop, PhD1*, Deepak Singhal, MBBS, MD, FRACP, FRCPA2,4,5*, David M Ross, MD, PhD, FRACP, FRCPA4,5,6*, David T Yeung, MBBS, PhD, BSc, FRACP, FRCPA1,2,3, Anna Brown, PhD5*, Hamish S Scott, PhD5, Christopher N. Hahn, PhD5,7*, Daniel Thomas, MD, PhD1,3,8, Chung How Kok, BSc, PhD3* and Devendra Hiwase, MD, MBBS, PhD, FRACP, FRCPA1,2,3
1Royal Adelaide Hospital, Adelaide, SA, Australia
2University of Adelaide, Adelaide, SA, Australia
3South Australian Health and Medical Research Institute, Adelaide, SA, Australia
4South Australian Health and Medical Research Institute, Adelaide, Australia
5SA Pathology, Adelaide, SA, Australia
6Royal Adelaide Hospital and SA Pathology, Adelaide, SA, Australia
7University of South Australia, Adelaide, SA, Australia
8University of Adelaide, Stanford, CA
Julie Braish, MD1*, Guillermo Montalban-Bravo, MD2, Farhad Ravandi, MBBS3, Nicholas J. Short, MD2, Tapan M. Kadia, MD2, Maro Ohanian, DO2*, Kelly S. Chien, MD4, Lucia Masarova, MD2, Koji Sasaki, MD2, Musa Yilmaz, MD2*, Naval Daver, MD1, Gautam Borthakur, MD5, Hagop M. Kantarjian, MD2 and Guillermo Garcia-Manero, MD2
1MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, MD Anderson, Houston, TX
5Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Mikkael A. Sekeres, MD1, Valeria Santini2*, Amer M. Zeidan, MBBS, MHS3, Uwe Platzbecker, MD4, Rami S. Komrokji, MD5, Maria Diez-Campelo, MD, PhD6*, Pierre Fenaux, MD7, Michael R. Savona, MD8*, Yazan F. Madanat, MD9, David Valcarcel, MD, PhD10, Antoine Regnault11*, Kristin Creel, MSc12*, Nishan Sengupta, PhD13*, Souria Dougherty, MBA13*, Sheetal Shah, BA13*, Libo Sun, PhD13*, Ying Wan, MD, PhD13*, Shyamala Navada, MD14* and Esther Natalie Oliva, MD15
1Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
2MDS Unit, Hematology, University of Florence, DMSC, AOUC, Florence, Italy
3Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, New Haven, CT
4Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
5Moffitt Cancer Center, Tampa, FL
6Hospital Clínico Universitario de Salamanca, Salamanca, Spain
7Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France
8Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN
9Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
10Department of Hematology and Oncology, Hospital Universitario Vall d'Hebron, Barcelona, Spain
11Modus Outcomes, a THREAD company, Lyon, France
12Modus Outcomes, a Division of THREAD, Lyon, France
13Geron Corporation, Foster City, CA
14Executive Medical Director, Geron, Foster City, CA
15Hematology Unit, Grande Ospedale Metropolitano BMM, Reggio Calabria, Reggio Calabria, Italy
Vasileios Papadopoulos*, Dimitrios Koparanis, MSc*, George Vrachiolias*, Christina Misidou*, Konstantinos Liapis, MD, PhD, Menelaos Konstantinos Papoutselis, MD* and Ioannis Kotsianidis, PhD
Democritus University of Thrace, Department of Hematology, University Hospital of Alexandroupolis, Alexandroupolis, Greece, Alexandroupolis, Greece
Ian M. Bouligny, MD1, Guillermo Montalban-Bravo, MD1, Koji Sasaki, MD1, Naval Daver, MD2, Elias Jabbour, MD1, Yesid Alvarado Valero, MD1, Courtney D. DiNardo, MD, MSc3, Farhad Ravandi, MBBS4, Naveen Pemmaraju, MD5, Tapan M. Kadia, MD1, Lucia Masarova, MD1, Koichi Takahashi, MD, PhD6, Michael Andreeff, MD, PhD7, Alexandre Bazinet, MD1*, Hui Yang, PhD, MD1, Rashmi Kanagal-Shamanna, MD8, Sherry Pierce, BSN, BA1*, Meghan Anne Meyer, BSN, RN1*, Xuelin Huang, PhD9* and Guillermo Garcia-Manero, MD1
1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Bellaire, TX
6Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
7Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
9Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
Mithun V Shah, M.D., Ph.D.1, Kevin Hung, MBBS, FRACP, FRCPA2, Anmol Baranwal, MBBS1*, Zoe Price, BSc (Hons)3*, Aref Al-Kali, MD4, Carla Toop, PhD2*, Patricia Greipp, DO5, Anna Brown, PhD6*, Dariusz Ladon, PhD7*, Dong Chen, MD, PhD5, Kebede Begna, MD8, Monika Kutyna, PhD9*, Danielle Rud1*, Mark R. Litzow, MD1, William J. Hogan, MD1, Peter Bardy, MBBS10,11*, Talha Badar, MD12, Sharad Kumar, PhD13*, David T Yeung, MBBS, PhD, BSc, FRACP, FRCPA2,14,15, Mrinal M. Patnaik, MD, MBBS4, James M. Foran, MD16, Rong He, MD5, Naseema Gangat, MBBS1, Hamish S Scott, PhD6,13, Cecilia Y. Arana Yi, MD17, Hassan B Alkhateeb, MD1*, Abhishek A. Mangaonkar, MBBS4, Daniel Thomas, MD, PhD, FRACP, FRCPA14,18, Christopher N. Hahn, PhD6,19*, Attilio Orazi, MD20*, Daniel A. Arber, MD21, Chung Hoow Kok, PhD, BSc22,23, Ayalew Tefferi, MD1 and Devendra Hiwase, MD, MBBS, PhD, FRACP, FRCPA14,15
1Division of Hematology, Mayo Clinic, Rochester, MN
2Royal Adelaide Hospital, Adelaide, SA, Australia
3Central Adelaide Local Health Network, Adelaide, SA, Australia
4Mayo Clinic, Rochester, MN
5Division of Hematopathology, Mayo Clinic, Rochester, MN
6SA Pathology, Adelaide, SA, Australia
7Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia
8Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
9Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia
10Department of Haematology, Central Adelaide Local Health Network, Adelaide, SA, Australia
11Haematology Department, Sa Pathology, Adelaide, Australia
12Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL
13Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia
14South Australian Health and Medical Research Institute, Adelaide, SA, Australia
15University of Adelaide, Adelaide, SA, Australia
16Division of Hematology & Medical Oncology, Mayo Clinic, Jacksonville, FL
17Division of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ
18Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia
19University of South Australia, Adelaide, SA, Australia
20Texas Tech University Health Sciences Center, El Paso
21University of Chicago, Chicago, IL
22Centre for Cancer Biology and SA Pathology, Adelaide, Australia
23Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia
Maria Julia Montoro, MD, PhD1*, Pamela Acha1*, Manja Meggendorfer, PhD2, Najla H Al Ali, MS3*, Víctor Navarro4*, Sherry Pierce, BSN, BA5*, Carlos Bravo-Perez, MD6*, Marie Adeline Migeon7*, Mestre Julia8*, Klaus H Metzeler, MD9, Michael Wulfert10*, Andres Jerez, MD, PhD1*, Marina Díaz-Beyá, MD, PhD11*, Beate Betz12*, Emmanuelle Clappier, Pharm.D., Ph.D.13*, Mar Tormo, MD14*, Helena Pomares15*, Mónica Del Rey16*, Silvia Saumell, MD, PhD17*, Laura Barbero18*, María Eugenia Rivero, MD19*, Maria Diez-Campelo, MD, PhD20*, David Sallman, MD21, Teresa Ezponda22*, Weina Chen, MD, PhD23*, Zhuoer Xie, MD, MS3, Francesc Bosch, MD, PhD24, Ulrich Germing, MD25*, Uwe Platzbecker, MD9, Francesc Sole, PhD26, Pierre Fenaux, MD27, Jaroslaw Maciejewski6, Guillermo Garcia-Manero, MD5, Rami S. Komrokji, MD3, Torsten Haferlach, MD28 and David Valcarcel, MD, PhD29
1Department of Hematology, Vall d'Hebron University Hospital, Barcelona, Spain
2MLL Munich Leukemia Laboratory, Munich, Bavaria, Germany
3Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
4Oncology Data Science (ODysSey), Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitario Vall d’Hebron, Barcelona, Spain
5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
7Interne - Service Hématologie Sénior, Hôpital Saint Louis, St Louis, France
8MDS Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Badalona, Spain
9Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
10Department of Haematology, Oncology and Immunology, Düsseldorf University Hospital, Düsseldorf, Germany
11Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain
12Institute for Human Genetics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
13Saint Louis Hospital, Paris, France
14Department of Hematology, Hospital Clínico de Valencia, Valencia, Spain
15Clinical Hematology Department, ICO-Hospitalet, Hospital Durán i Reynals. IDIBELL, Barcelona., Barcelona, Spain
16Department of Hematology, Salamanca-IBSAL University Hospital, Salamanca, Spain
17Department of Hematology, Hospital Universitari Vall d'Hebron, Barcelona, Spain
18Department of Hematology, Hospital Ramón y Cajal, Madrid, Spain
19Department of Hematology, Hospital Arnau de Vilanova, Lérida, Spain
20University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Department of Hematology - Hospital Universitario de Salamanca, Salamanca, Spain
21Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
22Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain
23Department of Pathology, UT Southwestern Medical Center, Dallas, TX
24Hematology Department, Hospital Universitario Vall d’Hebron, Barcelona, Spain
25Department of Hematology, Oncology and Clinical Immunology, University Medical Center Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany
26Myelodysplastic Syndromes Research Group, Institut De Recerca Josep Carreras, Badalona, Barcelona, Spain
27Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France
28MLL Munich Leukemia Laboratory, Munich, Germany
29Department of Hematology, Vall d’Hebron Institute of Oncology, University Hospital Vall d’Hebron,, Barcelona, Spain
Jan Philipp Bewersdorf, MD1, Xiaoli Mi, MD2, Bin Lu1*, Andrew T. Kuykendall, MD3, David Sallman, MD3, Manish Patel, MD4*, Don A. Stevens, MD5, Alexander Philipovskiy, MD, PhD6*, Grerk Sutamtewagul, MD7, Lucia Masarova, MD8, Gina Keiffer, MD9, Amit Verma, MD10, Neha Bhagwat, PhD11, Diane Heiser, PhD11*, Sunhee Ro, PhD11*, Wan-Jen Hong11, Omar Abdel-Wahab, MD12 and Eytan M. Stein, MD13
1Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Medicine, Cell Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4Florida Cancer Specialists, Sarah Cannon Research Institute, Sarasota, FL
5Norton Cancer Institute, Louisville, KY
6Florida Cancer Specialists, Sarah Cannon Research Institute, Lake Mary, FL
7Holden Comprehensive Cancer Center, University of Iowa Healthcare, Iowa City, IA
8Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
9Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, PA
10Blood Cancer Institute, Department of Oncology, Albert Einstein College of Medicine, Bronx, NY
11Prelude Therapeutics Incorporated, Wilmington, DE
12Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
13Department of Medicine; Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY
Esther Natalie Oliva, MD1, Uwe Platzbecker, MD2, Matteo Giovanni Della Porta, MD3*, Guillermo Garcia-Manero, MD4, Valeria Santini5*, Pierre Fenaux, MD6, Jake Shortt7*, Rami S. Komrokji, MD8, Christopher G. Pelligra9*, Shien Guo, PhD10*, Aylin Yucel11*, Mrudula B. Glassberg12*, Laurie Eliason11*, Ahmed Hnoosh13*, Dimana Miteva14*, Shelo Rose11, Sandra Kreitz14*, Mikkael A. Sekeres, MD15 and Amer M. Zeidan, MBBS, MHS16
1Hematology Unit, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy
2Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
3Cancer Center IRCCS Humanitas Research Hospital, Milan, Italy and Department of Biomedical Sciences, Humanitas University, Milan, Italy
4Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX
5MDS Unit, Hematology, University of Florence, DMSC, AOUC, Florence, Italy
6Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France
7Monash University and Monash Health, Melbourne, VIC, Australia
8Moffitt Cancer Center, Tampa, FL
9Evidera, Atlanta, GA
10Evidera, Bethesda, MD
11Bristol Myers Squibb, Princeton, NJ
12Bristol Myers Squibb, Madison, NJ
13Bristol Myers Squibb, Uxbridge, United Kingdom
14Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland
15Division of Hematology, Sylvester Cancer Center, University of Miami, Miami, FL
16Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, New Haven, CT
Rami S. Komrokji, MD1, Zena Komrokji1*, Najla H. Al Ali, Ms2*, Zhuoer Xie, MD, MS1, Onyee Chan, MD3*, Andrew T. Kuykendall, MD1, Joseph E. Jabbour4*, Alison R. Walker, MD, MBA, MPH1, Jeffrey E Lancet, MD1, Eric Padron, MD1 and David Sallman, MD5
1Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
2Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
5Moffitt Cancer Center and Research Institute, Tampa, FL
Talha Badar, MD1, Mobachir El Kettani, MD2*, Kashish J. Shah, MBBS2*, Terra L. Lasho, PhD3, Yael Kusne, MD, PhD4, Christy M Finke5*, James M. Foran, MD6, Mohamed A. Kharfan-Dabaja, MD, MBA7, Hemant S. Murthy, MD2, Yao-Shan Fan, MD, PhD2, Liuyan Jiang, MD8*, Naseema Gangat, MBBS5, Abhishek A. Mangaonkar, MBBS3, Aref Al-Kali, MD3,5,9, Ludovica Marando, MD, PhD9, Ayalew Tefferi, MD5, Rong He, MD10, David Viswanatha, MD11, Mark R. Litzow, MD5 and Mrinal M. Patnaik, MD, MBBS3
1Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL
2Mayo Clinic, Jacksonville, FL
3Mayo Clinic, Rochester, MN
4Mayo Clinic, Phoenix, AZ
5Division of Hematology, Mayo Clinic, Rochester, MN
6Division of Hematology & Medical Oncology, Mayo Clinic, Jacksonville, FL
7Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
8Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine and Science, Jacksonville
9Mayo Clinic, Rochester
10Division of Hematopathology, Mayo Clinic, Rochester, MN
11Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester
Ted M. Getz, MD1, Tariq Kewan, MD2, Jan Philipp Bewersdorf, MD3,4, Jessica M. Stempel, MD2, Luca Lanino, MD5, Wei Wei, MD, PhD6, Najla H. Al Ali, Ms7*, Amy E. DeZern, MD, MHS8, Mikkael A. Sekeres, MD9, Geoffrey L. Uy, MD10, Hetty E. Carraway, MD, MBA11, Pinkal Desai12, Elizabeth A. Griffiths, MD13, Eytan M. Stein, MD14, Andrew M. Brunner, MD15, Christine M. McMahon, MD16, Rory M. Shallis, MD17, Joshua F. Zeidner, MD18, Michael R. Savona, MD19, Somedeb Ball, MD19, Namrata S. Chandhok, MD20, Constantine Logothetis, MD21, Aram Bidikian, MD2, Gail J. Roboz, MD22, Benjamin Rolles, MD23,24, Eunice S. Wang, MD25, Amyah C. Harris15*, Maria L Amaya, MD, PhD26, Hayley Hawkins19*, Justin Grenet, MD, MPhil12, Zhuoer Xie, MD, MS27, Yazan F. Madanat, MD28, Yasmin Abaza, MD29, Talha Badar, MD30, Torsten Haferlach, MD31, Jaroslaw Maciejewski32, David Sallman, MD7, Anoop K Enjeti, MBBS, FRCPA, MD, MRCP33, Kamal Al-Rabi, MD34*, Khalid Halahleh, M.B.S.S.34*, Devendra Hiwase, MD, MBBS, PhD, FRACP, FRCPA35, Maria Diez-Campelo, MD, PhD36*, David Valcarcel, MD, PhD37, Claudia Haferlach, MD31, Lisa Pleyer, MD38*, Ioannis Kotsianidis, PhD39, Vasiliki Pappa, MD, PhD40, Valeria Santini, MD41, Angela Consagra, MD42*, Aref Al-Kali, MD43, Seishi Ogawa, MD, PhD44, Yasuhito Nannya, MD, PhD44, Maximilian Stahl, MD45, Matteo Giovanni Della Porta, MD46*, Rami S. Komrokji, MD27 and Amer M. Zeidan, MBBS, MHS2
1Department of Internal Medicine, Section of Hematology, Yale University, Jersey City, NJ
2Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
3Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, New Haven, CT
4Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
5IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy
6School of Public Health, Department of Biostatistics, Yale University, New Haven, CT
7Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
8Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore
9Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
10Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO
11Department of Hematology and Medical Oncology, Taussig Cancer Institute, Leukemia Program, Cleveland Clinic, Cleveland, OH
12Weill Cornell Medicine, New York, NY
13Roswell Park Comprehensive Cancer Center, Buffalo, NY
14Department of Medicine; Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY
15Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
16University of Colorado School of Medicine, Denver, CO
17Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, Killingworth, CT
18Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill
19Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN
20Sylvester Comprehensive Cancer Center, University of Miami-Miller School of Medicine, Miami, FL
21Division of Oncology, Washington University School of Medicine, Saint Louis, MO
22Department of Medicine, Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY
23Division of Hematology, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA
24Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
25Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
26University of Colorado, Aurora, CO
27Department of Malignant Hematology, H Lee Moffitt Cancer Center, Tampa, FL
28Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
29Northwestern University, Chicago, IL
30Division of Hematology-Oncology, Mayo Clinic, Jacksonville
31MLL Munich Leukemia Laboratory, Munich, Germany
32Taussig Cancer Center, Cleveland, OH
33Department of Haematology, Calvary Mater Hospital, Waratah, NSW, Australia
34King Hussein Cancer Center, Amman, Jordan
35Royal Adelaide Hospital, Adelaide, SA, Australia
36Hematology Department, Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, Salamanca, Spain
37Department of Hematology and Oncology, Hospital Universitario Vall d'Hebron, Barcelona, Spain
383rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectiology, Oncologic Center, Salzburg, Austria
39Democritus University of Thrace, Department of Hematology, University Hospital of Alexandroupolis, Alexandroupolis, Greece, Alexandroupolis, Greece
40Hematology Division, Second Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece
41MDS Unit, Hematology, AOU Careggi ‐ Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
42MDS Unit, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
43Mayo Clinic, Rochester, MN
44Department of Pathology and Tumor Biology, Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan
45Dana Farber Cancer Institute, Boston, MA
46Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy
Travis L Jensen, MS1*, Matthew D Bradley, BS1*, Ling Zhang, MD2*, Rafael Bejar, MD, PhD3, R. Coleman Lindsley, MD4, Matthew J. Walter, MD5 and Johannes Goll, MS1*
1The Emmes Company, Rockville, MD
2Hematopathology and Laboratory Medicine, Moffitt Cancer Center & Research Institute, Tampa, FL
3University of California, San Diego, La Jolla, CA
4Dana-Farber Cancer Institute, Boston, MA
5Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO
Anne Sophie Kubasch, MD1, Katharina Zoldan, Dr.1*, Michael Cross, Dr.1*, Marie Schneider1*, Jens Przybilla2*, Dirk Hasenclever, PhD2,3*, Klaus H Metzeler, MD1 and Uwe Platzbecker, MD1
1Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Medical Center Leipzig, Leipzig, Germany
2Clinical Trial Centre (ZKS), Leipzig, Germany
3Institute for Medical Informatics, Statistics & Epidemiology (IMISE), Leipzig, Germany
Uwe Platzbecker, MD1, Steven W Lane, MBBS, PhD, FRCPA, FRACP2, Alice Garnier, MD3*, Thomas Cluzeau, MD, PhD4, Odile Rauzy, MD5*, Katharina S. S. Götze, MD6, Aristoteles Giagounidis, MD7, Deepak Singhal, MBBS, MD, FRACP, FRCPA8*, Aicha Kopecky, PhD9*, Fatiha Chermat, PhD10* and Lionel Ades, MD, PhD11
1Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
2Cancer Program, QIMR Berghofer Medical Research Institute, Royal Brisbane and Women’s Hospital, Brisbane, QLD, Australia
3CHU Nantes Hôpital Hôtel Dieu Hématologie Clinique, Nantes, France
4Department for Clinical Hematology, Nice University Hospital, Nice, Provence Alpes Cote d'Azur, France
5Department for Internal Medicine, Toulouse University Hospital, Toulouse, France
6Department of Medicine III, Hematology and Oncology, Technical University of Munich School of Medicine, Munich, Germany
7Dept. for Oncology, Hematology and Palliative Care, Marienhospital Düsseldorf, Düsseldorf, Germany
8University of Adelaide, Adelaide, SA, Australia
9GCP-Service International, Bremen, Germany
10Groupe Francophone des Myelodysplasies, Paris, France
11Hopital Saint Louis, Paris, France
Julie A.I. Thoms, PhD1*, Feng Yan, PhD2*, Henry R. Hampton, PhD1*, Sarah Davidson, RN3*, Swapna Joshi, MSc4*, Jesslyn Saw, BSc5*, Chowdhury H. Sarowar, PhD4*, Xin Ying Lim, PhD4*, Andrea C Nunez, PhD4*, Purvi M. Kakadia, PhD6*, Golam Sarower Bhuyan, PhD4*, Xiaoheng Zou, MSc1*, Mary Nguyen, BSc1*, Elaheh S Ghodousi, MSc1*, Forrest C Koch, BSc7*, Fatemeh Vafaee, PhD7*, I. Richard Thompson8*, Mohammad M. Karimi, PhD8*, Russell Pickford, PhD9*, Mark J Raftery, PhD9*, Sally Hough10*, Griselda Buckland3*, Michelle Bailey10*, Yuvaraj Ghodke3*, Noorul Absar10*, Lachlin Vaughan, MBBS, PhD11*, Leonardo Pasalic, MBBS, PhD12*, Chun Yew Fong, MBBS, FRACP, FRCPA, PhD13*, Melita Kenealy14*, Devendra Hiwase, MD, MBBS, PhD, FRACP, FRCPA15, Rohanna Stoddart, MD16*, Soma Mohammed17*, Linda Lee18*, Freda H Passam, MD, PhD19, Stephen Robert Larsen, MBBS PhD FRACP FRCPA20, Kevin J Spring21*, Kristen K Skarratt22*, Patricia Rebeiro23*, Peter Presgrave, MBBS24, William S Stevenson, MBBS, FRACP, FRCPA, PhD25*, Silvia Ling26*, Campbell Tiley27*, Stephen Fuller22*, Fernando Roncolato28*, Anoop K Enjeti, MBBS, FRCPA, MD, MRCP29, Dirk Hoenemann, MD30*, Charlotte Lemech31*, Christopher J Jolly, PhD1*, Stefan K. Bohlander, MD6*, David J. Curtis, MBBS, PhD5, Jason Wong, PhD32*, Ashwin Unnikrishnan, PhD4, Mark S. Hertzberg, MD33, Jake Olivier, PhD34*, Mark N Polizzotto3* and John E Pimanda, MBBS, PhD, FRACP, FRCPA35
1School of Biomedical Sciences, University of New South Wales, Randwick, Australia
2Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
3ANU Clinical Hub for Interventional Research (CHOIR), John Curtin School of Medical Research, Canberra, Australia
4School of Clinical Medicine, University of New South Wales, Randwick, Australia
5Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia
6Leukaemia and Blood Cancer Research Unit, Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
7School of Biotechnology and Biomolecular Sciences, University of New South Wales, Randwick, Australia
8Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King’s College London, London, United Kingdom
9Bioanalytical Mass Spectrometry Facility, University of New South Wales, Randwick, Australia
10Kirby Institute, University of New South Wales, Randwick, Australia
11Westmead Hospital, Sydney, Australia
12Westmead Hospital, Westmead, Australia
13Department of Hematology, Austin Health, Heidelberg, VIC, Australia
14Cabrini Hospital, Melbourne, Australia
15Royal Adelaide Hospital, Adelaide, SA, Australia
16University of New South Wales, Randwick, Australia
17ICPMR, Department of Haematology, Westmead Hospital, Westmead, Australia
18Royal North Shore Hospital, Sydney, Australia
19Haematology Research Group, Heart Research Institute, Sydney, NSW, Australia
20Royal Prince Alfred Hospital, Camperdown, Australia
21Medical Oncology Group, Liverpool Clinical School, Western Sydney University, Liverpool, Australia
22Sydney Medical School, Nepean Clinical School, University of Sydney, Kingswood, Australia
23Blacktown Hospital, Blacktown, Australia
24Wollongong Hospital, Wollongong, Australia
25Royal North Shore Hospital, Sydney, AUS
26Liverpool Hospital, Liverpool, Australia
27Central Coast Health, Gosford Hospital, Gosford, Australia
28St George Hospital, Kogarah, Australia
29Department of Haematology, Calvary Mater Hospital, Waratah, NSW, Australia
30Otway Pharmaceutical Development and Consulting Pty Ltd, Forrest, Australia
31Scientia Clinical Research Limited, Sydney, Australia
32School of Biomedical Sciences, The University of Hong Kong, Hong Kong, SAR, China
33Prince of Wales Hospital and University of New South Wales, Sydney, Australia
34School of Mathematics and Statistics, University of New South Wales, Randwick, AUS
35School of Biomedical Sciences, University of New South Wales, Sydney, NSW, Australia
Xin Yan Sr., MD1*, Yulu Tian2*, Yan Gu2*, Chunhua Song, M.D., Ph.D.3 and Zheng Ge, MD, PhD4
1Department of Hematology, Zhongda Hospital, Institute of Hematology Southeast University, School of Medicine, Southeast University, Nanjing, China
2Department of Hematology, Zhongda Hospital, Institute of Hematology Southeast University, School of Medicine, Southeast University,, Nanjing, China
3The Division of Hematology, The Ohio State University Wexner Medical Center, the James Cancer Hospital, Columbus, OH
4Department of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Institute of Hematology Southeast University, Nanjing, China
Guillermo Garcia-Manero, MD1, David Sallman, MD2, Stefano R Tarantolo, MD3, Amit Verma, MD4, Stefanie Groepper, MD5*, Alice Mims, MD6, Yasmin Abaza, MD7, James P. Dugan, MD8, Valle Gomez G De Soria, MD9*, Gaurav S Choudhary, PhD10*, Maureen Lane, PhD10*, Wanying Zhao, PhD10*, Ashish Jain, MS10*, Cole Gallagher, BS10* and Uwe Platzbecker, MD11
1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3Nebraska Cancer Specialists, Omaha, NE
4Hematology/Oncology, Montefiore Medical Center/ Albert Einstein College of Medicine, Bronx, NY
5Marien Hospital, University of Düsseldorf, Düsseldorf, Germany
6Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
7Northwestern Medicine, Chicago, IL
8Malignant Hematology and Cellular Therapy Department, Novant Health Cancer Institute - Forsyth Medical Center, Winston, Salem, NC
9Hospital Universitario La Princesa, Madrid, Spain
10Curis Inc., Lexington, MA
11Leipzig University Hospital, Leipzig, Germany
Gabrielle T. Prince, MD1*, Praneeth Baratam, MBBS2, Guillermo Garcia-Manero, MD3, Anne Angiolillo, MD4*, Tarun Bhagnani, MS, BPharm4*, Assaf Vestin, PhD4* and Amir T. Fathi, MD5
1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
2Medical University of South Carolina/Hollings Cancer Center, Charleston, SC
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Servier Pharmaceuticals, Boston, MA
5Center for Leukemia, Massachusetts General Hospital Cancer Center, Boston, MA
Hammad Tashkandi, MD1, Xiaohui Zhang, MD, PhD2,3*, Rami S. Komrokji, MD4, Najla H. Al Ali, Ms5*, Zhuoer Xie, MD, MS4, Alison R. Walker, MD, MBA, MPH6, Eric Padron, MD7, Jeffrey E Lancet, MD7, David Sallman, MD7 and Ling Zhang, MD1*
1Hematopathology and Laboratory Medicine, Moffitt Cancer Center & Research Institute, Tampa, FL
2Department of Pathology, H. Lee Moffitt Cancer Center, Tampa, FL
3University of South Florida College of Medicine, Tampa, FL
4Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
5Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL
6Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Wesley Chapel, FL
7Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
Rami S. Komrokji, MD1, Najla H. Al Ali, Ms2*, Zhuoer Xie, MD, MS1, Zena Komrokji1*, Joseph E. Jabbour3*, Onyee Chan, MD4*, Seongseok Yun, MD, PhD1, Andrew T. Kuykendall, MD1, Alison R. Walker, MD, MBA, MPH1, Jeffrey E Lancet, MD1, Eric Padron, MD1 and David Sallman, MD5
1Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
2Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
4H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
5Moffitt Cancer Center and Research Institute, Tampa, FL
Rami S. Komrokji, MD1, Maria Diez-Campelo, MD, PhD2,3,4*, Lynette C.Y. Chee, MBBS, PhD, FRACP, FRCPA5,6, Thomas Cluzeau, MD, PhD7*, Amy E. DeZern, MD, MHS8, Pierre Fenaux, MD9, Guillermo Garcia-Manero, MD10, Aristoteles Giagounidis, MD11, Uwe Platzbecker, MD12, Matteo Giovanni Della Porta, MD13,14*, Valeria Santini, MD15,16, Mikkael A. Sekeres, MD17, Amer M. Zeidan, MD18, Rena Buckstein, MD, FRCPC19, Miranda Ross20*, Ying Jiang, PhD, MBA20*, Suresh Bobba20*, Montagu Hankin, MSc20*, Chris Materna, MSc20*, Christine Graham, PhD20*, Sanjay Thamake, PhD, MBA20*, Christopher Rovaldi, MSc20*, Dena Grayson, MD, PhD20* and Jen L. Salstrom, MD, PhD20
1Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
2Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain
3Department of Hematology, Salamanca-IBSAL University Hospital, Salamanca, Spain
4University Hospital of Salamanca, Salamanca, Spain
5Department of Medicine, The University of Melbourne, Parkville, VIC, Australia
6ACRF Laboratory, The Royal Melbourne Hospital, Parkville, VIC, Australia
7Hematology Department, Nice University Hospital, Cote d’Azur University, Nice, France
8The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
9Hopital Saint Louis, Groupe Francophone des Myelodysplasies, Paris, France, PARIS, FRA
10MD Anderson, Houston
11Clinic for Hematology, Oncology and Palliative Care Marien Hospital Düsseldorf, Dusseldorf, Germany
12University Hospital of Leipzig, Leipzig, Germany
13IRCCS Humanitas Research Hospital and Humanitas University, Rozzano, Milan, Italy
14Humanitas University, Milan, Italy
15AOU Careggi, University of Florence, Firenze, Italy
16MDS Unit, AOU Careggi, DMSC, University of Florence, Firenze, Italy
17Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
18Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
19Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
20Kero's Therapeutics, Lexington